^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    GENE:

    MIR7704 (MicroRNA 7704)

    i
    Other names: MIR7704, MicroRNA 7704, Hsa-Mir-7704, MicroRNA Mir-7704, MIMAT0030019, MI0025240
    Associations

    News

    Trials
    8ms
    Long noncoding HOXD-AS1: a crucial regulator of malignancy. (PubMed, Front Cell Dev Biol)
    It is a therapeutic target and biomarker for early diagnosis and prognosis, with good clinical application prospects. This article reviews the role, molecular mechanisms, and potential clinical value of HOXD-AS1 in malignant tumor development.
    Review • Journal
    |
    MIR7704 (MicroRNA 7704)
    over1year
    A miRNA-7704/IL2RB/AKT feedback loop regulates tumorigenesis and chemoresistance in ovarian cancer. (PubMed, Exp Cell Res)
    Furthermore, IL2RB reversed the miR-7704 mediated resistance to cisplatin in ovarian cancer. Based on these findings, miR-7704 and IL2RB show the potential as novel therapeutic targets for ovarian cancer.
    Journal
    |
    MIR7704 (MicroRNA 7704)
    |
    cisplatin
    over2years
    Crosstalk between Long Non-Coding RNA and Spliceosomal microRNA as a Novel Biomarker for Cancer. (PubMed, Noncoding RNA)
    Because the expression of spliceosomal miRNA is cell-type-specific, the list of cis-interacting lncRNA:spliceosomal miRNA presented here is likely just the tip of the iceberg, and such interactions are likely relevant to additional cancers. We thus highlight the potential of lncRNA:spliceosomal miRNA interactions as novel targets for cancer diagnosis and therapies.
    Review • Journal
    |
    MIR7704 (MicroRNA 7704)